Alternative Mood Stabilizers for Bipolar II Maintenance When Lithium and Lamotrigine Are Contraindicated
When lithium and lamotrigine cannot be used for bipolar II maintenance, valproate (divalproex) should be your first alternative, followed by quetiapine as a second option, with careful consideration of metabolic side effects.
Primary Alternative: Valproate (Divalproex)
Valproate represents the most evidence-based alternative after lithium and lamotrigine for bipolar maintenance therapy 1. The medication has FDA approval for acute mania in adults and demonstrates efficacy in preventing mood episode recurrence 1. While the evidence base is stronger for bipolar I disorder, valproate's mood-stabilizing properties extend to bipolar II patients, particularly those with rapid cycling or mixed features 1.
Key monitoring requirements:
- Baseline: liver function tests, complete blood count, pregnancy test
- Ongoing: serum drug levels (target 40-90 mcg/mL), hepatic and hematological indices every 3-6 months 1
- Critical caveat: Valproate is absolutely contraindicated in people of childbearing potential due to severe teratogenic and neurodevelopmental risks in offspring 2. Recent evidence suggests potential risks even with paternal exposure 2.
Secondary Alternative: Quetiapine
If valproate is unsuitable, quetiapine emerges as the strongest second-line option 3, 4. This atypical antipsychotic has demonstrated efficacy across all phases of bipolar disorder—acute mania, bipolar depression, and maintenance treatment 1, 3. The 2018 CANMAT/ISBD guidelines rank quetiapine as first-line for both acute bipolar depression and maintenance treatment in bipolar I disorder, with evidence extending to bipolar II 3.
Practical considerations:
- More sedating than other options—can be advantageous for sleep disturbances 1
- Requires vigilant metabolic monitoring: baseline and ongoing assessment of BMI, waist circumference, blood pressure, fasting glucose, and lipid panel 1
- Monitor BMI monthly for 3 months, then quarterly; metabolic labs at 3 months, then yearly 1
Third-Line Options
Carbamazepine
Carbamazepine has some support for maintenance therapy but with important limitations 1. The evidence is more equivocal than valproate, and it may lose prophylactic effectiveness over time 5. Additionally, carbamazepine carries teratogenic risks and should be avoided in those of childbearing potential 2.
If used:
- Initial dose: 100 mg twice daily, titrate to therapeutic level (4-8 mcg/mL) 6
- Monitor CBC and liver enzymes regularly due to problematic side-effect profile 6
Other Atypical Antipsychotics
Olanzapine, aripiprazole, and risperidone have FDA approval for maintenance therapy in adults 1. However, all atypical antipsychotics carry significant metabolic burden, particularly olanzapine 1, 7. The 2018 CANMAT guidelines include asenapine and aripiprazole as first-line maintenance options 3.
Critical Decision-Making Algorithm
Step 1: Assess childbearing potential
- If yes → Avoid valproate and carbamazepine → Proceed to quetiapine
- If no → Valproate is preferred alternative
Step 2: Evaluate metabolic risk factors
- Pre-existing diabetes, obesity, dyslipidemia → Consider valproate over atypical antipsychotics
- If metabolic concerns preclude both → Consider combination therapy or specialist referral
Step 3: Consider illness characteristics
- Predominant depression → Quetiapine preferred (stronger antidepressant properties) 3
- Rapid cycling → Valproate may be particularly effective 1
- Psychotic features → Atypical antipsychotics advantageous 1
Important Caveats
Combination therapy is often necessary: Monotherapy proves inadequate for long-term management in most bipolar patients 5. The emerging consensus indicates that patients on monotherapy will eventually require concomitant treatment to maintain full remission 5.
Evidence limitations for bipolar II: The certainty of evidence for all treatments in bipolar II specifically is very low 8. Most recommendations extrapolate from bipolar I data and adult literature 1.
Avoid these agents: Controlled studies demonstrate that gabapentin and topiramate are not helpful for bipolar maintenance 1. Clozapine should be reserved only for treatment-refractory cases due to its side-effect profile 1.
Antidepressant caution: If depressive symptoms predominate, antidepressants (preferably SSRIs) may be added but only in combination with a mood stabilizer, never as monotherapy, due to risks of mood destabilization and manic switching 1.